MDM2-p53 antagonist (BI 907828): mechanism of action

Dr. Gounder on his CD paper MDM2–p53 antagonist BI 907828 in patients w/advanced or met solid tumorsПодробнее

BI 907828: targeting MDM2 in solid tumorsПодробнее

Inhibiting MDM2 to promote apoptosis in ALLПодробнее

MDM2 inhibition in MFПодробнее

Исследование связи структура-активность ингибиторов взаимодействия Mdm2-p53Подробнее

Spirooxindole Scaffold as a Potential Inhibitor for p53-MDM2 InteractionПодробнее

Natural product-like MDM2 inhibitorsПодробнее

The Role of p53 and MDM2 in Cancer GrowthПодробнее

MDM4/MDM2-p53-IGF1R in nerve regenerationПодробнее

The Role of p53 in CancerПодробнее

Bridging Micro- and Macroscopic Mechanisms of p53-MDM2 Binding Using Mol. Simulations & Kinetic...Подробнее

MDM2 inhibition in AML: trial updatesПодробнее

SIRPα antagonist (BI 765063): mechanism of actionПодробнее

p53 Target Genes: feedback loop regulation of p53 by mdm2Подробнее

Yale Cancer Center Grand Rounds | April 6, 2021Подробнее

What effect does idasanutlin have on TP53-mutated clones in patients with polycythemia vera?Подробнее

P53 Apoptosis SignalingПодробнее

p53 stapled analogs binding to MDM2Подробнее